Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 201-210 of 406 for multiple

Edit search filters
  1. SMAC Mimetic LCL161 Alone Or With Cyclophosphamide In Treating Patients With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Dose Escalation Study Of I-131-CLR1404 In Patients With Relapsed Or Refractory Multiple Myeloma

    Jacksonville, FL

  3. A Study Evaluating ABT-199 In Multiple Myeloma Subjects Who Are Receiving Bortezomib And Dexamethasone As Standard Therapy

    Jacksonville, FL, Rochester, MN

  4. Selinexor, Carfilzomib, And Dexamethasone In Treating Patients With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ

  5. A Study Comparing JNJ-79635322 And Teclistamab In Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Study To Evaluate The Safety And Efficacy Of KITE-585 In Participants With Relapsed/Refractory Multiple Myeloma

    Rochester, MN

  7. NEXUS Study: A Study To Test Single And Multiple Doses Of MER511 Given To Adults With Graves' Disease

    Rochester, MN

  8. A Phase 1/2 Study Of CYT-0851 In B-Cell Malignancies And Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study To Evaluate Single Vs. Multiple Dose Regimens Of Privigen In Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

    Rochester, MN

  10. Study Of Pomalidomide And Low Dose Dexamethasone With Or Without Pembrolizumab (MK-3475) In Refractory Or Relapsed And Refractory Multiple Myeloma (RrMM) (MK-3475-183/KEYNOTE-183)

    Jacksonville, FL

.

Mayo Clinic Footer